Taro Announces New $250 Million Share Repurchase Authorization


This authorization follows the successful completion of the previous $250 million share repurchase program in August 2016. Repurchases may be made from time to time at the Company's discretion, based on ongoing assessments of the capital needs of the business, the market price of its stock, and general market conditions.



from Biotech News